Unlocking Opportunities Rare Diseases: How Consulting Services Empower Pharma Companies
Rare diseases, often referred to as orphan diseases, affect a small percentage of the population, typically defined as fewer than 200,000 individuals in the United States or fewer than 1 in 2,000 people in Europe. While their individual prevalence may be low, the global burden of rare diseases is significant, with over 7,000 distinct conditions ide